Clinical Trial Update: Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

View source ↗

Summary

This clinical trial update describes the development of a database to study digital and blood-based biomarkers and their relationship to tau and amyloid PET ima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Early-onset Alzheimer Disease

Snippet

Sponsor: GAP Innovations, PBC | Conditions: Mild Cognitive Impairment, Alzheimer's Disease | Status: RECRUITING